Insider Transactions last 24 months for Repare Therapeutics Inc.  -  NSDQ: RPTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Alves Sandra Isabelle BarrosSVP, Finance and CAO04/02/2025AADirectCOM4,100$0.00$0.0029,622
Segal Lloyd MitchellPRESIDENT AND CEO03/12/2025DSDirectCOM21,179$1.14$24,144.06124,394
Forte SteveEVP, CHIEF FINANCIAL OFFICER03/12/2025DSDirectCOM6,884$1.14$7,847.7654,786
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER03/12/2025DSDirectCOM5,611$1.14$6,396.5480,297
Koehler MariaEVP, CHIEF MEDICAL OFFICER03/12/2025DSDirectCOM3,596$1.14$4,099.44227,813
Forte SteveEVP, CHIEF FINANCIAL OFFICER03/04/2025AADirectCOM14,000$0.00$0.0061,670
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER03/04/2025AADirectCOM14,000$0.00$0.0085,908
Segal Lloyd MitchellPRESIDENT AND CEO03/04/2025AADirectCOM40,000$0.00$0.00145,573
Koehler MariaEVP, CHIEF MEDICAL OFFICER04/01/2024DSDirectCOM300$4.66$1,398.00231,409
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER04/01/2024DSDirectCOM410$4.66$1,910.6071,908
Forte SteveEVP, CHIEF FINANCIAL OFFICER04/01/2024DSDirectCOM789$4.61$3,637.2944,775
Segal Lloyd MitchellPRESIDENT AND CEO04/01/2024DSIndirectCOM2,491$4.63$11,533.33107,558
Koehler MariaEVP, CHIEF MEDICAL OFFICER03/28/2024DSDirectCOM500$4.64$2,320.00231,709
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER03/28/2024DSDirectCOM450$4.64$2,088.0072,318
Forte SteveEVP, CHIEF FINANCIAL OFFICER03/28/2024DSDirectCOM825$4.62$3,811.5045,564
Segal Lloyd MitchellPRESIDENT AND CEO03/28/2024DSIndirectCOM2,650$4.62$12,243.00110,049
Segal Lloyd MitchellPRESIDENT AND CEO03/27/2024DSIndirectCOM2,650$4.63$12,269.5083,866
Koehler MariaEVP, CHIEF MEDICAL OFFICER03/27/2024DSDirectCOM500$4.62$2,310.00232,209
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER03/27/2024DSDirectCOM450$4.62$2,079.0072,768
Forte SteveEVP, CHIEF FINANCIAL OFFICER03/27/2024DSDirectCOM825$4.62$3,811.5042,212
Segal Lloyd MitchellPRESIDENT AND CEO03/26/2024DSIndirectCOM2,650$4.64$12,296.0086,516
Koehler MariaEVP, CHIEF MEDICAL OFFICER03/26/2024DSDirectCOM500$4.60$2,300.00232,709
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER03/26/2024DSDirectCOM450$4.61$2,074.5073,218
Forte SteveEVP, CHIEF FINANCIAL OFFICER03/26/2024DSDirectCOM825$4.60$3,795.0043,037
Segal Lloyd MitchellPRESIDENT AND CEO03/25/2024DSIndirectCOM2,650$4.79$12,693.5089,166
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel